Buprenorphine hydrochloride and naloxone hydrochloride dihydrate sublingual tablet (2 mg/0.5 mg and 8 mg/2 mg) clinical trials

Symptom-Inhibited Naloxone Induction (SINI) for Buprenorphine Initiation: A Feasibility Trial

This study is testing a new way to start treatment for opioid use disorder. It involves giving a medicine called naloxone to bring on mild withdrawal, then buprenorphine to ease symptoms. It aims to see if this method is safe and works well.